Home GeneSys

GeneSys

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Most Important Questions for Interview Preparation

April 7, 2020

Interview Questions – Medical Representative

April 20, 2020

Heat Stroke | Symptoms | Causes | Complications | Prevention |...

June 24, 2023

HOT NEWS

Interview Questions

Interview Questions – Area Manager in Pharmaceutical Companies

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Role and Responsibilities

Role & Responsibilities of Pharma Product Manager | Pharma PMT Job...

Learning and Development